LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹30 Cr | ₹26 Cr | ₹51 Cr | ₹73 Cr | ₹73 Cr |
What is the latest Total Non-Current Liabilities ratio of LYKA LABS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹30 Cr |
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹51 Cr |
| Mar2023 | ₹73 Cr |
| Mar2022 | ₹73 Cr |
How is Total Non-Current Liabilities of LYKA LABS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹30 Cr | 14.67 | |
| Mar2025 | ₹26 Cr | -48.85 | |
| Mar2024 | ₹51 Cr | -30.63 | |
| Mar2023 | ₹73 Cr | 0.66 | |
| Mar2022 | ₹73 Cr | - | |
Compare Total Non-Current Liabilities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹218.3 Cr | -7.1% | -16.2% | -47.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,993.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -7.1% |
-16.2% |
-47.8% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses